
|Articles|May 1, 2005
How to treat refractory OAB using injectable botulinum toxin
No patient has developed urinary retention or elevated post-void residuals following our modified injection technique.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
NDV-01 produces robust 9-month results in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
SUO 2025 data confirm IsoPSA accuracy independent of mpMRI use
4
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
5


















